2470807-67-9

2470807-67-9 structure
2470807-67-9 structure
  • Name: Multi-kinase-IN-1
  • Chemical Name: Multi-kinase-IN-1
  • CAS Number: 2470807-67-9
  • Molecular Formula: C35H36F2N6O6S
  • Molecular Weight: 706.76
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-06-30 20:47:26
  • Modify Date: 2025-08-26 06:02:43
  • Multi-kinase-IN-1 (Compound 11k) is a potent kinase inhibitor with antitumor activity. Multi-kinase-IN-1 induces cell apoptosis, and can be studied for colorectal cancer[1].

Name Multi-kinase-IN-1
Description Multi-kinase-IN-1 (Compound 11k) is a potent kinase inhibitor with antitumor activity. Multi-kinase-IN-1 induces cell apoptosis, and can be studied for colorectal cancer[1].
Related Catalog
Target

c-Met:0.382 μM (IC50)

PDGFRα:0.384 μM (IC50)

Ron:0.122 μM (IC50)

c-Src:0.421 μM (IC50)

AXL:0.632 μM (IC50)

In Vitro Multi-kinase-IN-1 (Compound 11k) (0-5 µg/mL, 0-72 h) induces antiproliferation and cytotoxicity in a dose- and time-dependent manner in HT-29 cells, and is much less toxic to normal colorectal mucosa epithelial cells[1]. Multi-kinase-IN-1 (0-3 µg/mL, 0-72 h) induces cell apoptosis in a time- and dose-dependent manner[1]. Multi-kinase-IN-1 (0-3 µg/mL, 48 h) slightly induces cell cycle arrest in G2/M phase[1]. Cell Proliferation Assay[1] Cell Line: HT-29 (human colon cancer cell) and FHC (normal colorectal mucosa epithelial cells) Concentration: 0.56, 1.67, and 5 µg/mL for HT-29, 10 µg/mL for FHC Incubation Time: 0-72 h Result: Led to significant cytotoxicity in a dose- and time-dependent manner in HT-29 cells. Showed low toxicity in FHC cells. Apoptosis Analysis[1] Cell Line: HT-29 Concentration: 0.3, 1, and 3 µg/mL Incubation Time: 0-72 h Result: Induced cell apoptosis in a time- and dose-dependent manner. Cell Cycle Analysis[1] Cell Line: HT-29 Concentration: 0.3, 1, and 3 µg/mL Incubation Time: 48 h Result: Slightly induced cell cycle arrest with a G2/M percentage of 4.4% at 3.0 mg/mL compared to 0.1% DMSO (2.4%).
References

[1]. Yuting Zhou, et al. Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer. Eur J Med Chem. 2020 Oct 15;204:112643.

Molecular Formula C35H36F2N6O6S
Molecular Weight 706.76
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.